To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

215.50a day ago
227.67a day ago
arrow

LOWER/UPPER CIRCUITS

208.04
229.93
arrow
Suven Life Sciences Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteQuarterly Revenue,rose 85.56% YoY to ₹2.47 Cr. Its sector's average revenue growth YoY for the quarter was 16.15%.
noteDebt to Equity Ratio,is zero as the company is debt-free.
noteStock Price,rose 44.08% and outperformed its sector by 20.31% in the past year.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : -16.09%
Net profit growth 5Y CAGR : %
Suven Life Sciences Ltd Top mutual funds holding
arrow
Suven Life Sciences provides wide range of Drug Discovery and Development Support Services (DDDSS) to global Pharma and Biotech companies. Suven has state-of-art facilities with highly qualified & experienced team of scientists. Suven offer research services specializing in Synthetic Medicinal and Analytical Chemistry In-vitro Assay development and Screening Drug Metabolism & Pharmacokinetics CNS Pharmacology (Behavioral Pharmacology Microdialysis Receptor Occupancy Electrophysiology) Toxicology and Safety Pharmacology Bioanalysis and NCE Formulations.
personal

Grow your wealth with more research recommendations

+91